Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Now that semaglutide’s no longer in shortage territory, the FDA said drug-makers have 90 days to wrap up production of their Novo knockoffs.
Last Tuesday, content conglomerate Thomson Reuters notched a big legal win against AI firm ROSS. Is it a sign of what’s to come?
De Beers, one of the largest companies in the diamond mining sector, has been battered by the ascendance of cheaper lab-grown gems.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
It took a few extra innings, but Amazon and Main Street Sports Group have finally come to an agreement after a year of circling each other.
There are signs that the emissions-free long haul semi-truck industry is slowly but surely picking up momentum, with or without Nikola.
The sector has been soaring on an atomic tailwind thanks to the energy demands of AI-hungry tech companies.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
While the continent is not on par with the US in terms of defense spending, the uptick in VC activity is mirrored across the Atlantic.
McDonald’s had a good quarter, but the numbers from the US market show the value menu math isn’t quite mathing yet.
Shares of US steel and aluminum companies rose Monday, bolstered by a fresh round of tariff threats from the Trump administration.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.